Page 21 - Gena Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Senior Vice President of Investor Relations Good evening. Welcome to the Vertex First Quarter 2021 Financial Results Conference Call. This is Michael Partridge, Senior Vice President of Investor Relations for Vertex. Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Commercial and Operations Officer and Charlie Wagner, Chief Financial Officer. We recommend that you access the webcast slides on our website as you listen to this call. This conference call is being recorded and a replay will be available on our website...

Alnylam Pharmaceuticals Inc (ALNY) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) Q1 2021 Earnings Call Operator Thank you for standing by and welcome to the Alnylam Pharmaceuticals First Quarter 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder today's program is being recorded. And now I'd like to introduce y...

Moderna The Moderna vaccine only hit UK shores for distribution today, but it has been a major driver behind the US’ rapid immunisation programme. The drug was first rolled out in America in December, with President Joe Biden’s order for 600m doses almost enough to vaccinate the entire US population. Moderna has said it expects sales of $18.4bn (£13bn) this year — far higher than the $11.2bn predicted by analysts. The vast sales will push Moderna into profit for the first time in its 11-year history, and see its reputation cemented among global pharma giants.  So far, Moderna has fina...

The St Kitts Nevis Observer From Pfizer to Moderna: who’s making billions from Covid-19 vaccines? The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies. Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are both charging more than $30 per person for the protection of their two-dose vaccines. While Moderna was founded just 11 years ago, has never made a profit and employed just 830 staff pre-pandemic, Pfize...

The companies in line for the biggest windfalls – and the shareholders who have already made fortunes